4.3 Article

Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm

Journal

IMMUNOBIOLOGY
Volume 220, Issue 2, Pages 200-209

Publisher

ELSEVIER GMBH
DOI: 10.1016/j.imbio.2014.09.018

Keywords

V-set and immunoglobulin domain-containing 4 (Vsig4); Complement receptor of the Ig superfamily (CRIg); Kupffer cells; Concanavalin A (ConA); Hepatitis; SPECT/mu CT; Nanobody

Categories

Funding

  1. Agency for Innovation by Science and Technology
  2. National Fund for Scientific Research Flanders
  3. Concerted Research Actions of the Regional Government of Flanders
  4. Interuniversity Attraction Poles
  5. Top-Notch Student Scholarship Fund of China Scholarship Council

Ask authors/readers for more resources

Kupffer cells (KCs) are liver resident macrophages which are important for tissue homeostasis and have been implicated in immunogenic, tolerogenic and pathogenic immune reactions depending on the insult. These cells and the biomarkers they express thus represent interesting in vivo sensors for monitoring liver inflammation. In the current study, we explored whether KCs can be monitored non-invasively using single-photon-emission computed tomography (SPECT) with Tc-99m labeled nanobodies (Nbs) targeting selected biomarkers. Nbs targeting V-set and immunoglobulin domain-containing 4 (Vsig4) or macrophage mannose receptor (MMR) accumulated in the liver of untreated mice. The liver targeting of anti-Vsig4 Nbs, but not anti-MMR Nbs, was blunted upon depletion of macrophages, highlighting specificity of anti-Vsig4 Nbs for liver macrophage imaging. Ex vivo flow cytometry and immunohistochemistry analysis confirmed that anti-Vsig4 Nbs specifically targeted KCs but no other cell types in the liver. Upon induction of acute hepatitis using concanavalin A (ConA), down-regulation of the in vivo imaging signal obtained using anti-Vsig4 Nbs reflected reduction in KC numbers and transient modulation of Vsig4 expression on KCs. Overall, these results indicate that Nbs targeting Vsig4 as molecular imaging biomarker enable non-invasive monitoring of KCs during hepatic inflammation. (C) 2014 Elsevier GmbH. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available